[PDF][PDF] Антигипертензивные и плейотропные эффекты моно-и комбинированной антигипертензивной терапии у больных артериальной гипертонией и …
ИВ Кузнецова - gnicpm.ru
Артериальная гипертония (АГ)-один из основных факторов риска (ФР) развития
мозгового инсульта, коронарной болезни сердца (КБС), инфаркта миокарда (ИМ) …
мозгового инсульта, коронарной болезни сердца (КБС), инфаркта миокарда (ИМ) …
Pharmacologic strategies for the prevention of atherosclerotic plaque progression
P Schoenhagen, T Crowe, M Tuzcu… - Expert Review of …, 2004 - Taylor & Francis
Despite improved treatment options, coronary artery disease remains the leading cause of
death in men and women in industrialized societies. Reduction of atherosclerotic disease …
death in men and women in industrialized societies. Reduction of atherosclerotic disease …
Amlodipine/atorvastatin single pill for the management of hypertensive patients with additional cardiovascular risk factors
R Blank - 2006 - Future Medicine
Amlodipine besylate and atorvastatin calcium have been demonstrated in numerous clinical
trials to be highly effective in lowering blood pressure and low-density lipoprotein …
trials to be highly effective in lowering blood pressure and low-density lipoprotein …
[PDF][PDF] Research Journal of Pharmaceutical, Biological and Chemical Sciences
MB Tehrani, M Shoorvazi, E Souri - researchgate.net
ABSTRACT A simple, sensitive and selective derivative spectrophotometry has been
developed for the determination of amlodipine and atorvastatin in their combined …
developed for the determination of amlodipine and atorvastatin in their combined …
Lasidipinin sıçanlarda indometazinle oluşturulan ülserlere etkisi
B Süleyman - acikbilim.yok.gov.tr
Bu çalışmada, lasidipinin antiülser aktivitesi, sıçanlarda indometazinle oluşturulan ülser
modelinde araştırıldı ve antiülser aktivitesinin mide dokusundaki oksidan-antioksidan …
modelinde araştırıldı ve antiülser aktivitesinin mide dokusundaki oksidan-antioksidan …
Evaluation of Efficacy & Biochemical Effects of Amlodipine/Atorvastatin with Essential Hypertension
AALAR Fida, MIIA Akund - Medical Forum Monthly, 2013 - medicalforummonthly.com
Introduction: An adequate blood pressure is a treatment of hypertension and it is the risk of
cardiovascular morbidity and mortality so proper therapy is essential. Combination therapy …
cardiovascular morbidity and mortality so proper therapy is essential. Combination therapy …
Drug Therapy and Follow-Up
M Eandi - Atherosclerosis Disease Management, 2011 - Springer
Atherosclerosis is a systemic disease of the arteries and is considered the leading cause of
cardiovascular diseases (CVDs), coronary artery disease (CAD), peripheral artery disease …
cardiovascular diseases (CVDs), coronary artery disease (CAD), peripheral artery disease …
Patsient s arterial'noy gipertoniey: v fokuse amlodipin
SV Nedogoda - Consilium Medicum, 2009 - consilium.orscience.ru
В настоящее время для лечения артериальной гипертензии (АГ) используется 6
основных классов антигипертензивных средств, а в каждом из них имеется как …
основных классов антигипертензивных средств, а в каждом из них имеется как …
Hochaufgelöste Magnetresonanz-Bildgebung der Mäuseaorta zur Bestimmung der Dynamik funktioneller Parameter durch Laufrad-Training bei ApoE-Knock-Out …
W Offenberger - 2009 - opus.bibliothek.uni-wuerzburg.de
Einführung: Atherosklerose ist eine führende Ursache von Morbidität und Mortalität weltweit.
Die ApoE-Knock-Out-Maus (ApoE-/-) ist das wichtigste Tiermodell für das Studium der …
Die ApoE-Knock-Out-Maus (ApoE-/-) ist das wichtigste Tiermodell für das Studium der …
[PDF][PDF] Características farmacológicas de
LE YAGO - Innova, 2009 - clubdelafarmacia.com
Puesta: 34-35 Puesta al día 2 19/10/09 1: 49 Página 36 den con un incremento del número
de receptores LDL de su superficie y mayor captación de moléculas de cLDL circulantes y …
de receptores LDL de su superficie y mayor captación de moléculas de cLDL circulantes y …